AFT Pharmaceuticals SA (Pty) Ltd (‘AFT SA’) announces it has successfully completed the acquisition of the Hospital Division business of Pharma Dynamics (Pty) Ltd (‘Pharma Dynamics’).
AFT SA is a subsidiary of AFT Pharmaceuticals Limited (“AFT Pharmaceuticals), a multinational pharmaceutical company listed on the New Zealand Stock Exchange (NZX) and Australian Stock Exchange (ASX).
Since its inception in 1998, AFT Pharmaceuticals has built a proven track record for the development, manufacture and licensing of a wide range of over-the-counter, prescription and hospital medicines, now available more than 85 countries worldwide.
Established in South Africa 11 months ago, AFT SA’s strategy has initially focused on hospital-based medicines.
“As an organisation committed to high-quality products and exceptional customer support, this acquisition is an ideal fit,’ says AFT SA Chief Executive Deon Hall. “Pharma Dynamics’ strong portfolio will help us to build market presence in hospitals and continue its legacy.”
The transaction was completed on 28 November 2025, with a phased transition plan underway since early October to maintain operations and stock supply.
“Both companies are committed to a smooth handover, and we are working closely together to ensure this occurs. We also look forward to building strong, enduring relationships with our customers and partners,” says Hall.
Click here for further information about AFT SA, its team and products. A list of the products acquired from Pharma Dynamics is provided on the next page.
For further information:
Deon Hall
Chief Executive Officer
AFT SA
Email : deon.hall@aftpharm.com
Mobile : +27 832268475
